Skip to main content

Paediatric Aggressive Mature B Cell Non-Hodgkin Lymphoma (Burkitt lymphoma)

- Scope and purpose

This guideline was developed aiming to enhance the quality of care for paediatric Burkitt lymphoma (NHL) patients by establishing a consistent standard of care nationwide. They focus on aiding in the early diagnosis, treatment, and follow-up of Burkitt lymphoma to achieve better clinical outcomes.

➡️Target audience

Clinicians who are involved in the care and treatment of patients with Burkitt lymphoma (NHL), including paediatric oncologists, surgeons, radiologists, pathologists, and palliative care specialists.